We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2280:TADAWULAlmarai Company Analysis

Data as of 2026-07-15 - not real-time

SAR 46.64

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Almarai shares are trading at SAR 46.64, comfortably above the 20‑day (SAR 45.99), 50‑day (SAR 45.31) and 200‑day (SAR 44.65) moving averages, signaling a solid bullish bias. The MACD line sits at +0.42 above its signal (+0.40), producing a bullish histogram, while the RSI of 56 shows momentum is still in the neutral‑to‑positive zone. The price is anchored by a near‑term support at SAR 44.30 and faces resistance around SAR 47.30, leaving roughly a 2.7% upside in the immediate range. Market sentiment is extremely optimistic, as reflected by a Fear‑Greed Index of 92.5 (Extreme Greed) and a consensus “Strong Buy” from 17 analysts with a median target of SAR 58.
On the fundamentals side, Almarai delivered SAR 23.0 bn of revenue last year, growing 11% YoY, and generated a healthy operating margin of 13.9% and profit margin of 10.6%. Return on equity stands at 12.2% and cash flow from operations is robust at SAR 5.28 bn, supporting the current 2.47% dividend yield with a payout ratio of just 40%. However, the balance sheet carries a high debt‑to‑equity ratio of 69.7% and free cash flow is negative (‑SAR 1.66 bn), indicating that leverage and capital‑intensive investments remain a cautionary point. The discounted‑cash‑flow model values the company at SAR 62.36, implying roughly a 22% upside from today’s price and a 13% upside versus the analyst median target. Valuation multiples (PE ≈ 19, PB ≈ 2.2) are modest relative to peers, reinforcing the view that the stock is undervalued on a fair‑value basis. Given the low beta of 0.07 and a 30‑day volatility of about 20%, price swings are contained, while the defensive consumer‑staples sector buffers against macro‑economic shocks. In summary, the confluence of bullish technical signals, attractive dividend yield, solid earnings growth, and a sizable valuation upside makes Almarai a compelling buy in the near to medium term. Investors should still monitor debt levels and free‑cash‑flow trends, but the current risk‑adjusted profile remains favorable.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 8/10

Key Factors

  • Price above all major moving averages
  • Bullish MACD and supportive RSI
  • Strong analyst consensus with upside potential

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF fair value indicating ~22% upside
  • 11% revenue growth and solid margins
  • Sustainable 2.47% dividend yield

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Defensive consumer staples positioning
  • Brand strength and diversified product portfolio
  • Undervalued valuation multiples despite high leverage

Key Metrics & Analysis

Financial Health

Revenue Growth11.00%
Profit Margin10.62%
P/E Ratio19.0
ROE12.23%
ROA4.78%
Debt/Equity69.66
P/B Ratio2.2
Op. Cash FlowSAR5.3B
Free Cash FlowSAR-1661924096

Technical Analysis

TrendBullish
RSI56.5
SupportSAR 44.30
ResistanceSAR 47.30
MA 20SAR 46.00
MA 50SAR 45.31
MA 200SAR 44.65
MACDBullish
VolumeIncreasing
Fear & Greed Index92.52

Valuation

Fair ValueSAR 62.36
Target PriceSAR 57.21
Upside/Downside22.65%
GradeUndervalued
TypeBlend
Dividend Yield2.47%

Risk Assessment

Beta0.07
Volatility20.48%
Sector RiskLow
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.